PDCD1 and neoplasm: To avoid systemic administration of PD-1 antibodies, PD-1 depletion/knock-out using gene editing in transferred anti-tumor T-cells or TCR-equipped T-cells is considered a strategy to locally block T-cell inhibition [40,47].